about
Toxocariasis: clinical aspects, epidemiology, medical ecology, and molecular aspectsCerebral Toxocariasis: Silent Progression to Neurodegenerative Disorders?Highlights of human toxocariasisClinical and serological evidence of Toxocara infection in school children from Morrope district, Lambayeque, Peru.Frequency of eosinophilia and risk factors and their association with Toxocara infection in schoolchildren during a health survey in the north of Lima, Peru.Frequency of human toxocariasis in a rural population from Cajamarca, Peru determined by DOT-ELISA test.Development of a highly specific recombinant Toxocara canis second-stage larva excretory-secretory antigen for immunodiagnosis of human toxocariasisSeropositivity for ascariosis and toxocariosis and cytokine expression among the indigenous people in the Venezuelan Delta region.Immunopathological changes in the brain of immunosuppressed mice experimentally infected with Toxocara canis.Analysis of the course and treatment of toxocariasis in children-a long-term observationVisceral larva migrans in immigrants from latin americaPleural effusion and toxocariasis.Aspects of Toxocara epidemiology: human toxocarosis.MRI in cerebral toxocaral disease.Larva migrans syndrome caused by Toxocara and Ascaris roundworm infections in Japanese patients.Detection of Specific Antibody Reactivity to Toxocara Larval Excretory-secretory Antigens in Asthmatic Patients (5-15 Years).Global toxocariasis research trends from 1932 to 2015: a bibliometric analysis.Epidemiology and control of child toxocariasis in the western Brazilian Amazon - a population-based study.An abundantly expressed mucin-like protein from Toxocara canis infective larvae: the precursor of the larval surface coat glycoproteins.The co-occurrence of Toxocara ocular and visceral larva migrans syndrome: a case series.Sero-epidemiology of toxocariasis in school children.Human toxocariasis and pyogenic liver abscess: a possible association.In vitro production of Toxocara canis excretory-secretory (TES) antigen.Serological, clinical and epidemiological evaluation of toxocariasis in urban areas of south Brazil.Presence of visceral larva migrans in the urinary bladder of a woman in khorramabad, iran"Covert toxocariasis" in a child treated with low-dose diethylcarbamazine.Eosinophilic myelitis in the cervical cord mimicking intramedullary cord tumorToxocariasis: America's most common neglected infection of poverty and a helminthiasis of global importance?Toxocara canis and human health.Environmental exposure to Toxocara as a possible risk factor for asthma: a clinic-based case-control study.[Prevalence and risk factors of human infection by Toxocara canis in Salvador, State of Bahia, Brazil].Evaluation of immunodiagnostics for toxocarosis in experimental porcine cysticercosis.Toxocara infection and epilepsy in children: a case-control study.Prevalence of Toxoplasma gondii and Toxocara canis among Patients with Uveitis.Assessment of the diagnostic value of specific anti-Toxocara IgA in Slovakian patients suspected to have toxocarosis.Human toxocariasis: frequency of anti-Toxocara antibodies in children and adolescents from an outpatient clinic for lymphatic filariasis in Recife, Northeast Brazil.Persistent airway hyper-responsiveness and inflammation in Toxocara canis-infected BALB/c mice.Ocular toxocariasis in schoolchildren.Frequency and risk factors for toxocariasis in children from a pediatric outpatient center in southeastern Brazil.Toxocarosis in children: poor hygiene habits and contact with dogs is related to longer treatment.
P2860
Q24682965-5C5AC60B-27A8-4091-921F-A601ECD98A5FQ27693854-5C370FA2-C17B-4B96-B033-46B95B28636CQ28362535-FA2DC5F9-0A1E-44A1-9914-B44BA4E7383FQ33335713-9A5EA40D-CC3D-4F89-8CBA-5D5F644D1D63Q33379131-7863DD64-1155-4711-ADCA-321327D564DDQ33434534-580760CC-1653-41FD-9EF8-A18A942661D0Q33966345-9F8E3D9D-E1BB-4DC1-B4E0-0928CAFD9720Q35076185-F91397A1-CE85-4B4C-B8DE-57965FE01DA8Q35262181-3E36E6B5-1C95-45FD-8C76-E32B7DD69430Q35996233-C7D5C4DE-B070-49BC-9AE5-37FFF68F1D69Q36053074-9E0A7D37-2A99-4073-8700-AF284F70DAD3Q36506093-2572B322-4E75-4575-B435-537E247C3541Q36888181-708F5258-D6C1-4D53-ABA1-38C556429AA1Q36946567-433BD9FD-6686-4B2F-B549-5C99F03680D0Q37171174-3707FBD3-566A-4114-A020-90C742031FE0Q37387132-DAF79013-5C42-430D-9801-6FAD8F3548D9Q37663401-12DC188B-3739-43CC-8943-3A7A506020E7Q37680719-F9C7EFCE-D8D2-46F5-BAAF-D9C6376967FDQ37723643-63997EFA-2E75-4324-8B1D-B8047495E029Q39343613-927C7A94-02CE-4344-A337-CFB065EC8961Q39373496-20E84231-A521-4AF5-9A15-A65E08A5E263Q39387393-2D0A5164-AA89-4DBC-98AE-8F7DB978F341Q39411765-11EAAFBA-E315-453C-8CE2-4F19A1633221Q39932931-DC7D940E-3BC3-4786-87BB-2FE4EAD5FD0BQ40022207-DF5DEA9C-58ED-41E9-BDF7-76D5C1620A32Q40722910-32C7BCD7-C54D-4FC6-8BE2-387F6446FB09Q41506485-FD119ABF-1593-4FE2-A9CE-161D82EE0309Q42577897-1E2EE6AA-31E6-4EFA-8A61-F0903D1F2AB3Q42693571-099D56F6-5438-40EE-A864-8BC25FBC338FQ43215312-591B54FE-B4CD-425B-BE32-DBFCF1924AECQ43821646-66AC0E0F-2C6D-4A22-B62A-60ABEDE3C9D9Q44431934-06BD0761-6027-4251-8325-30DD9F94E7D5Q44709465-675A8DEB-7C44-474D-8109-15FFBDA971E8Q44827321-2C0032C2-3C82-4C93-B712-3CC8E7CDE949Q47584021-237388F9-76D5-4462-8899-E1A969F6B6FAQ47609533-53E1A22F-5712-45A9-A5C3-8E44F46523F4Q47776793-2F1EB28D-06AF-45A0-A2EB-3D5888EF6FE8Q47943314-048B0986-1AD3-4111-A1EF-723D7D2D833BQ51777812-5E4A47F2-B906-46B6-853C-A4D71519521DQ52647098-B91CF61D-E9CC-4154-8259-EB1572DE4B61
P2860
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
The expanded spectrum of toxocaral disease.
@en
type
label
The expanded spectrum of toxocaral disease.
@en
prefLabel
The expanded spectrum of toxocaral disease.
@en
P2093
P1433
P1476
The expanded spectrum of toxocaral disease.
@en
P2093
E Mulvihill
M R Taylor
P O'Connor
P304
P356
10.1016/S0140-6736(88)91486-9
P407
P577
1988-03-01T00:00:00Z